Tillkännagivande • Apr 24
Jiayuan Science and Technology Co.,Ltd., Annual General Meeting, May 15, 2026 Jiayuan Science and Technology Co.,Ltd., Annual General Meeting, May 15, 2026, at 14:50 China Standard Time. Location: The Company's Meeting Room, Chengdu, Sichuan China Reported Earnings • Apr 24
First quarter 2026 earnings released: CN¥0.19 loss per share (vs CN¥0.11 loss in 1Q 2025) First quarter 2026 results: CN¥0.19 loss per share (further deteriorated from CN¥0.11 loss in 1Q 2025). Revenue: CN¥28.5m (up 29% from 1Q 2025). Net loss: CN¥24.2m (loss widened 68% from 1Q 2025). Revenue is forecast to grow 42% p.a. on average during the next 2 years, compared to a 16% growth forecast for the IT industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Tillkännagivande • Mar 31
Jiayuan Science and Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 24, 2026 Jiayuan Science and Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026 Tillkännagivande • Dec 31
Jiayuan Science and Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 24, 2026 Jiayuan Science and Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 24, 2026 Major Estimate Revision • Dec 04
Consensus EPS estimates fall by 68% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from CN¥0.65 to CN¥0.21. Revenue forecast unchanged from CN¥385.0m at last update. Net income forecast to grow 281% next year vs 58% growth forecast for IT industry in China. Consensus price target up from CN¥42.00 to CN¥57.00. Share price fell 3.8% to CN¥46.62 over the past week. New Risk • Oct 29
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 39% per year over the past 5 years. High level of non-cash earnings (21% accrual ratio). New Risk • Oct 15
New major risk - Revenue and earnings growth Earnings have declined by 42% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 42% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Tillkännagivande • Sep 30
Jiayuan Science and Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 29, 2025 Jiayuan Science and Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025 Tillkännagivande • Jul 02
Jiayuan Science and Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 28, 2025 Jiayuan Science and Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 28, 2025 Tillkännagivande • Apr 25
Jiayuan Science and Technology Co.,Ltd. Proposes Final Cash Dividend for 2024 Jiayuan Science and Technology Co.,Ltd. proposed final cash dividend of CNY 0.20000000 per 10 shares (tax included) for 2024. Reported Earnings • Apr 24
First quarter 2025 earnings released: CN¥0.16 loss per share (vs CN¥0.17 loss in 1Q 2024) First quarter 2025 results: CN¥0.16 loss per share (improved from CN¥0.17 loss in 1Q 2024). Revenue: CN¥22.1m (up 36% from 1Q 2024). Net loss: CN¥14.4m (loss narrowed 8.8% from 1Q 2024). Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 15% growth forecast for the IT industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. Tillkännagivande • Apr 24
Jiayuan Science and Technology Co.,Ltd., Annual General Meeting, May 15, 2025 Jiayuan Science and Technology Co.,Ltd., Annual General Meeting, May 15, 2025, at 14:50 China Standard Time. Location: 1F, No. 333, Tianchen Road, Hi-tech Zone, Chengdu, Sichuan China New Risk • Apr 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Tillkännagivande • Mar 31
Jiayuan Science and Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 24, 2025 Jiayuan Science and Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025 Tillkännagivande • Dec 31
Jiayuan Science and Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025 Jiayuan Science and Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025 Price Target Changed • Oct 29
Price target increased by 13% to CN¥46.12 Up from CN¥40.70, the current price target is an average from 2 analysts. New target price is 39% above last closing price of CN¥33.11. Stock is down 49% over the past year. The company is forecast to post earnings per share of CN¥0.83 next year compared to a net loss per share of CN¥0.06 last year. Reported Earnings • Oct 27
Third quarter 2024 earnings released: CN¥0.29 loss per share (vs CN¥0.051 profit in 3Q 2023) Third quarter 2024 results: CN¥0.29 loss per share (down from CN¥0.051 profit in 3Q 2023). Revenue: CN¥38.4m (down 32% from 3Q 2023). Net loss: CN¥25.6m (down CN¥30.4m from profit in 3Q 2023). Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 15% growth forecast for the IT industry in China. Tillkännagivande • Sep 30
Jiayuan Science and Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 28, 2024 Jiayuan Science and Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 28, 2024 Reported Earnings • Aug 28
Second quarter 2024 earnings released: EPS: CN¥0.23 (vs CN¥0.21 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.23 (up from CN¥0.21 in 2Q 2023). Revenue: CN¥139.8m (up 78% from 2Q 2023). Net income: CN¥23.6m (up 23% from 2Q 2023). Profit margin: 17% (down from 24% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 15% growth forecast for the IT industry in China. New Risk • Jul 19
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company. Tillkännagivande • Jun 29
Jiayuan Science and Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024 Jiayuan Science and Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 28, 2024 Buy Or Sell Opportunity • May 30
Now 29% overvalued Over the last 90 days, the stock has fallen 16% to CN¥31.49. The fair value is estimated to be CN¥24.47, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.7% over the last 3 years. Meanwhile, the company became loss making. Price Target Changed • Apr 25
Price target decreased by 65% to CN¥31.40 Down from CN¥88.50, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of CN¥31.08. Stock is down 54% over the past year. The company is forecast to post earnings per share of CN¥1.84 next year compared to a net loss per share of CN¥0.06 last year. Reported Earnings • Apr 24
First quarter 2024 earnings released: CN¥0.17 loss per share (vs CN¥0.09 profit in 1Q 2023) First quarter 2024 results: CN¥0.17 loss per share (down from CN¥0.09 profit in 1Q 2023). Revenue: CN¥16.3m (down 68% from 1Q 2023). Net loss: CN¥15.8m (down 289% from profit in 1Q 2023). Revenue is forecast to grow 66% p.a. on average during the next 2 years, compared to a 19% growth forecast for the IT industry in China. Tillkännagivande • Apr 23
Jiayuan Science and Technology Co.,Ltd., Annual General Meeting, May 14, 2024 Jiayuan Science and Technology Co.,Ltd., Annual General Meeting, May 14, 2024, at 14:45 China Standard Time. Location: The Company's Meeting Room, Chengdu, Sichuan China Buy Or Sell Opportunity • Apr 22
Now 21% overvalued Over the last 90 days, the stock has fallen 23% to CN¥29.65. The fair value is estimated to be CN¥24.59, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has declined by 5.2%. Revenue is forecast to grow by 156% in 2 years. Earnings are forecast to grow by 306% in the next 2 years. Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to CN¥24.68, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 24x in the IT industry in China. Total loss to shareholders of 65% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.63 per share. Tillkännagivande • Mar 30
Jiayuan Science and Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 23, 2024 Jiayuan Science and Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 23, 2024 Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to CN¥31.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 28x in the IT industry in China. Total loss to shareholders of 59% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.12 per share. Price Target Changed • Mar 02
Price target decreased by 11% to CN¥77.75 Down from CN¥87.00, the current price target is an average from 2 analysts. New target price is 107% above last closing price of CN¥37.60. Stock is down 55% over the past year. The company is forecast to post earnings per share of CN¥1.11 for next year compared to CN¥0.68 last year. Buy Or Sell Opportunity • Feb 08
Now 20% overvalued Over the last 90 days, the stock has fallen 52% to CN¥28.51. The fair value is estimated to be CN¥23.68, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has declined by 5.2%. Revenue is forecast to grow by 187% in 2 years. Earnings are forecast to grow by 333% in the next 2 years. Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment deteriorates as stock falls 31% After last week's 31% share price decline to CN¥25.02, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 20x in the IT industry in China. Total loss to shareholders of 67% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥21.80 per share. Valuation Update With 7 Day Price Move • Jan 22
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥38.53, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 23x in the IT industry in China. Total loss to shareholders of 52% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥21.68 per share. Tillkännagivande • Dec 30
Jiayuan Science and Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 23, 2024 Jiayuan Science and Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 23, 2024 New Risk • Nov 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). High level of non-cash earnings (23% accrual ratio). Reported Earnings • Oct 26
Third quarter 2023 earnings released: EPS: CN¥0.051 (vs CN¥0.068 loss in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.051 (up from CN¥0.068 loss in 3Q 2022). Revenue: CN¥56.7m (up 331% from 3Q 2022). Net income: CN¥4.80m (up CN¥10.9m from 3Q 2022). Profit margin: 8.5% (up from net loss in 3Q 2022). The move to profitability was driven by higher revenue. Revenue is forecast to grow 50% p.a. on average during the next 3 years, compared to a 20% growth forecast for the IT industry in China. Price Target Changed • Sep 02
Price target decreased by 8.9% to CN¥79.25 Down from CN¥87.00, the current price target is an average from 2 analysts. New target price is 65% above last closing price of CN¥47.98. Stock is down 23% over the past year. The company is forecast to post earnings per share of CN¥1.23 for next year compared to CN¥0.68 last year. Reported Earnings • Aug 25
Second quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.51 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.51 in 2Q 2022). Revenue: CN¥78.6m (down 41% from 2Q 2022). Net income: CN¥19.2m (down 59% from 2Q 2022). Profit margin: 24% (down from 35% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 49% p.a. on average during the next 3 years, compared to a 19% growth forecast for the IT industry in China. Valuation Update With 7 Day Price Move • Jul 26
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥53.29, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 29x in the IT industry in China. Total loss to shareholders of 6.1% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥32.68 per share. New Risk • Jul 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (57% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.7% average weekly change). Board Change • Jul 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. Independent Director Qian'e Yang was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • May 27
Jiayuan Science and Technology Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 2 June 2023 Jiayuan Science and Technology Co.,Ltd. announced final cash dividend of CNY 1.50000000 per 10 shares (tax included) on A Shares for the year 2022. Record date is 1 June 2023, Ex-Date is 2 June 2023 and Payment Date is 2 June 2023. Reported Earnings • Apr 21
First quarter 2023 earnings released: EPS: CN¥0.09 (vs CN¥0.05 loss in 1Q 2022) First quarter 2023 results: EPS: CN¥0.09 (up from CN¥0.05 loss in 1Q 2022). Revenue: CN¥50.7m (up 254% from 1Q 2022). Net income: CN¥8.37m (up CN¥12.7m from 1Q 2022). Profit margin: 17% (up from net loss in 1Q 2022). The move to profitability was driven by higher revenue. Revenue is forecast to grow 54% p.a. on average during the next 2 years, compared to a 19% growth forecast for the IT industry in China. Buying Opportunity • Nov 29
Now 20% undervalued Over the last 90 days, the stock is up 33%. The fair value is estimated to be CN¥93.53, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 35% over the last 3 years. Earnings per share has grown by 33%. Revenue is forecast to grow by 161% in 2 years. Earnings is forecast to grow by 217% in the next 2 years. Major Estimate Revision • Nov 25
Consensus revenue estimates fall by 11% The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥470.5m to CN¥417.0m. EPS estimate fell from CN¥1.56 to CN¥1.34 per share. Net income forecast to grow 114% next year vs 58% growth forecast for IT industry in China. Consensus price target up from CN¥87.00 to CN¥99.84. Share price rose 10% to CN¥77.78 over the past week. Buying Opportunity • Nov 01
Now 21% undervalued Over the last 90 days, the stock is up 12%. The fair value is estimated to be CN¥93.45, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 35% over the last 3 years. Earnings per share has grown by 33%. Revenue is forecast to grow by 175% in 2 years. Earnings is forecast to grow by 236% in the next 2 years. Reported Earnings • Oct 25
Third quarter 2022 earnings released: CN¥0.068 loss per share (vs CN¥0.075 profit in 3Q 2021) Third quarter 2022 results: CN¥0.068 loss per share (down from CN¥0.075 profit in 3Q 2021). Revenue: CN¥13.2m (down 44% from 3Q 2021). Net loss: CN¥6.10m (down 214% from profit in 3Q 2021). Revenue is forecast to grow 42% p.a. on average during the next 3 years, compared to a 20% growth forecast for the IT industry in China. Valuation Update With 7 Day Price Move • Oct 17
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥65.55, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 23x in the IT industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥102 per share. Valuation Update With 7 Day Price Move • Sep 07
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥66.78, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 22x in the IT industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥114 per share. Reported Earnings • Aug 28
Second quarter 2022 earnings released: EPS: CN¥0.51 (vs CN¥0.66 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.51. Revenue: CN¥134.1m (up 3.1% from 2Q 2021). Net income: CN¥47.0m (flat on 2Q 2021). Profit margin: 35% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 71%, compared to a 25% growth forecast for the IT industry in China. Valuation Update With 7 Day Price Move • Jul 28
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥59.60, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 25x in the IT industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.70 per share. Tillkännagivande • May 12
Jiayuan Science and Technology Co.,Ltd. Implements Final Cash Dividend for 2021, Payable on 17 May 2022 Jiayuan Science and Technology Co.,Ltd. implemented final cash dividend per 10 shares (tax included) of CNY 4.00000000 for 2021. Record date is 16 May 2022. Ex-date is 17 May 2022. Payment date is 17 May 2022. Reported Earnings • Apr 27
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: CN¥0.05 loss per share (up from CN¥0.10 loss in 1Q 2021). Revenue: CN¥14.3m (up 359% from 1Q 2021). Net loss: CN¥4.30m (loss narrowed 36% from 1Q 2021). Revenue exceeded analyst estimates by 3.0%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 56%, compared to a 24% growth forecast for the industry in China. Board Change • Apr 27
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. Non-Employee Supervisor Yayang Zhang is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Tillkännagivande • Apr 13
Jiayuan Science and Technology Co.,Ltd. Announces the Profit Distribution Proposal for 2021 Jiayuan Science and Technology Co.,Ltd. announced the profit distribution proposal for 2021. The company announced Cash dividend/10 shares (tax included) of CNY 4.00000000. Reported Earnings • Apr 12
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: CN¥1.34 (up from CN¥0.76 in FY 2020). Revenue: CN¥316.8m (up 66% from FY 2020). Net income: CN¥92.5m (up 76% from FY 2020). Profit margin: 29% (up from 28% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 3.0%. Earnings per share (EPS) also surpassed analyst estimates by 17%. Over the next year, revenue is forecast to grow 46%, compared to a 24% growth forecast for the industry in China. Tillkännagivande • Feb 19
Jiayuan Science and Technology Co.,Ltd. Announces Executive Appointments Jiayuan Science and Technology Co.,Ltd. at its Extraordinary General Meeting of 2022 held on 17 February 2022, approved the appointment of Chen Zhipeng as non-independent directors; Yang Qian'e and Zhao Yuhong as independent directors; and Liu Beibei and Zhang Yayang as non-employee supervisors. 
